Monika Maleszewska
Overview
Explore the profile of Monika Maleszewska including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
465
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pouikli A, Parekh S, Maleszewska M, Nikopoulou C, Baghdadi M, Tripodi I, et al.
Nat Aging
. 2023 Apr;
1(9):810-825.
PMID: 37117628
Aging is accompanied by a general decline in the function of many cellular pathways. However, whether these are causally or functionally interconnected remains elusive. Here, we study the effect of...
2.
Pouikli A, Maleszewska M, Parekh S, Yang M, Nikopoulou C, Bonfiglio J, et al.
EMBO J
. 2022 Oct;
41(23):e111239.
PMID: 36278281
Bone-derived mesenchymal stem cells (MSCs) reside in a hypoxic niche that maintains their differentiation potential. While hypoxia (low oxygen concentration) was reported to critically support stem cell function and osteogenesis,...
3.
Maleszewska M, Vanchin B, Harmsen M, Krenning G
Angiogenesis
. 2015 Sep;
19(1):9-24.
PMID: 26416763
High uniform fluid shear stress (FSS) is atheroprotective and preserves the endothelial phenotype and function through activation of downstream mediators such as MAPK7 (Erk5). Endothelial cells respond to FSS thanks...
4.
Tertil M, Golda S, Skrzypek K, Florczyk U, Weglarczyk K, Kotlinowski J, et al.
Free Radic Biol Med
. 2015 Sep;
89:147-57.
PMID: 26393425
Lung mucoepidermoid carcinoma (MEC) is a very poorly characterized rare subtype of non-small-cell lung cancer (NSCLC) associated with more favorable prognoses than other forms of intrathoracic malignancies. We have previously...
5.
Moonen J, Lee E, Schmidt M, Maleszewska M, Koerts J, Brouwer L, et al.
Cardiovasc Res
. 2015 Jun;
108(3):377-86.
PMID: 26084310
Aims: Neointimal hyperplasia is a common feature of fibro-proliferative vascular disease and characterizes initial stages of atherosclerosis. Neointimal lesions mainly comprise smooth muscle-like cells. The presence of these lesions is...
6.
Maleszewska M, Gjaltema R, Krenning G, Harmsen M
Cell Signal
. 2015 Apr;
27(8):1589-96.
PMID: 25917318
Smooth muscle-22α (SM22α), encoded by transgelin (TAGLN), is expressed in mesenchymal lineage cells, including myofibroblasts and smooth muscle cells. It is an F-actin binding protein that regulates the organization of...
7.
Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, et al.
Antioxid Redox Signal
. 2013 Sep;
20(11):1693-708.
PMID: 24053644
Aims: Nuclear factor E2-related factor 2 (Nrf2), a key cytoprotective transcription factor, regulates also proangiogenic mediators, interleukin-8 and heme oxygenase-1 (HO-1). However, hitherto its role in blood vessel formation was...
8.
Maleszewska M, Moonen J, Huijkman N, van de Sluis B, Krenning G, Harmsen M
Immunobiology
. 2012 Jun;
218(4):443-54.
PMID: 22739237
Endothelial to mesenchymal transition (EndMT) contributes to fibrotic diseases. The main inducer of EndMT is TGFβ signaling. TGFβ2 is the dominant isoform in the physiological embryonic EndMT, but its role...